| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 10/19/2006 | US20060233719 Delivery of antidepressants through an inhalation route |
| 10/19/2006 | DE112004001502T5 Neurobeschützende und Anti-Proliferationsverbindungen Neurobeschützende and anti-proliferative compounds |
| 10/19/2006 | DE102005061519A1 Pyrrolderivate und Photosensitiver Film, der diese verwendet Pyrrole and photo-sensitive film that uses this |
| 10/19/2006 | CA2604773A1 Npy antagonists, preparation and use |
| 10/19/2006 | CA2604397A1 Process for preparing bicyclic compounds |
| 10/19/2006 | CA2604384A1 Process for preparing bicyclic compounds |
| 10/19/2006 | CA2604042A1 Hydroxybenzamide derivatives and their use as inhibitors of hsp90 |
| 10/19/2006 | CA2603941A1 Phenylacetamides suitable as protein kinase inhibitors |
| 10/19/2006 | CA2603637A1 Dna-pk inhibitors |
| 10/19/2006 | CA2603634A1 Novel isoindole derivatives, compositions containing same, preparation thereof and pharmaceutical uses thereof in particular as inhibitors of chaperone protein hsp90 activities |
| 10/19/2006 | CA2603457A1 Pyrazolo[1,5-a]pyridine derivatives or pharmaceutically acceptable salts thereof |
| 10/19/2006 | CA2601697A1 Preparation of tadalafil intermediates |
| 10/19/2006 | CA2598208A1 Tetrahydronaphthalene derivatives, processes for their preparation and their use as antiinflammatory agents |
| 10/18/2006 | EP1712549A1 Optically active quaternary ammonium salt having axial asymmetry and process for producing alpha-amino acid and derivative thereof with the same |
| 10/18/2006 | EP1711617A1 Method and compositions for identifying anti-hiv therapeutics compounds |
| 10/18/2006 | EP1711500A1 Diaza- or thiazadione derivatives with neuroprotective activity |
| 10/18/2006 | EP1711498A2 1,2,4-triazolo¬1,5-a|pyridines as gastric acid secretion inhibitors |
| 10/18/2006 | EP1711495A2 Quinoline, quinazoline, pyridine and pyrimidine counds and their use in the treatment of inflammation, angiogenesis and cancer |
| 10/18/2006 | EP1711488A1 Heterocyclic modulators of the glucocorticoid receptor, ap-1, and/or nf-kappa b activity and use thereof |
| 10/18/2006 | EP1711484A1 Synthesis of cyanoimino-benzoimidazoles |
| 10/18/2006 | EP1711469A1 Method for the production of terylene-3,4:11,12-tetracarboxydiimides by direct synthesis |
| 10/18/2006 | EP1711184A1 (3-oxo-3,4-dihydro-quinoxalin-2-yl-amino)-benzamide derivatives and related compounds as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity |
| 10/18/2006 | EP1414830B1 Tumour inhibiting lanthane compounds |
| 10/18/2006 | EP1414829B1 Tumour inhibiting cerium compounds |
| 10/18/2006 | EP1392686B1 Bicyclic nitrogen-containing heterocyclic derivatives for use as antibacterials |
| 10/18/2006 | EP1339714B1 Novel sulfonamide-substituted pyrazolopyridine derivatives |
| 10/18/2006 | EP1084710B1 Adenosine a1 antagonists for male sterility |
| 10/18/2006 | CN1849336A Chimeric gabab receptor |
| 10/18/2006 | CN1849320A Process for the preparation of renzapride and intermediates thereof |
| 10/18/2006 | CN1849319A Sulfonyldihydroimidazopyridinone compounds as 5-hydroxytryptamine-6 ligands |
| 10/18/2006 | CN1849316A 7-(4-substituted 3- cyclopropylaminomethyl-1- pyrrolidinyl) Q uinolonecarboxylic acid derivative |
| 10/18/2006 | CN1849126A 17-heterocyclic-4-azasteroid derivatives as androgen receptor modulators |
| 10/18/2006 | CN1847229A Novel compounds |
| 10/18/2006 | CN1846697A New use of angiotensin ii antagonists |
| 10/18/2006 | CN1280293C Improved method for making nevirapine |
| 10/18/2006 | CN1280292C Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors |
| 10/18/2006 | CN1280291C Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors |
| 10/18/2006 | CN1280275C Pyridione derivatives for tretment of atherosclerosis |
| 10/18/2006 | CN1280271C Arylphenyl-substituted cyclic keto-enols |
| 10/18/2006 | CN1280269C Aliphatic nitrogenous five-membered ring compounds |
| 10/18/2006 | CN1279934C Composite Chinese medicine for treating malignant solid tumor and its prepn. |
| 10/18/2006 | CN1279818C Herbicidal synergistic composition, and method of controlling weeds |
| 10/17/2006 | US7122679 Multicyclic compounds and the use thereof |
| 10/17/2006 | US7122666 Antiinflammatory agents; autoimmune disease; antiarthritic agents |
| 10/17/2006 | US7122663 Oxidation of alcohols to aldehydes, ketones, acids |
| 10/17/2006 | US7122662 Tricyclic compound having spiro union |
| 10/17/2006 | US7122643 Cytostatic lanthanum compounds |
| 10/17/2006 | US7122572 For use in Hydrogen Bonding Liquid Chromatography, environmental remediation by removal of undesired ions or neutral molecules, removal of phosphate for kidney dialysis, drug delivery, separation |
| 10/17/2006 | US7122557 5-chloro-N-(5-chloropyridin-2-yl)-2-[(4-{(Z)-(dimethylamino)[(methylsulfonyl)imino]methyl}benzoyl)amino]benzamide; treating thromboembolic disorders, optionally with other active agents |
| 10/17/2006 | US7122556 Phenylalanine enamide derivatives |
| 10/17/2006 | US7122555 Pyrido [2,1-a] isoquinoline derivatives |
| 10/17/2006 | US7122554 Sexual disorders therapy; hypotensive agents; chronic obstructive pulmonary disease; congestive heart failure; asthma; antiallergens |
| 10/17/2006 | US7122552 Antiallergens; autoimmune diseases; antiproliferative agents; controlling signal transduction |
| 10/17/2006 | US7122549 For therapy of cancer |
| 10/17/2006 | US7122545 Imidazo-benzothiazoles |
| 10/17/2006 | US7122539 lower gastrointestinal and cardiovascular side effects; use in treatment of respiratory system disorders, as tokolitics and as antiallergics, for eye applications. |
| 10/17/2006 | US7122534 Aryl fused azapolycyclic compounds |
| 10/17/2006 | US7122081 Reducing particle size of organic pigments by milling the crude pigment in the presence of a water soluble styrene copolymer dispersant, optionally a defoamer, optionally an additive, and greater than about 10 wt. % water, and isolating the organic pigment |
| 10/17/2006 | CA2447405C Tartrate salts of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof |
| 10/17/2006 | CA2395705C Substituted phenyl-piperazine derivatives, their preparation and use |
| 10/17/2006 | CA2238818C 1-(1,2-disubstituted piperidinyl)-4-substituted piperidine derivatives as tachykinin receptor antagonists |
| 10/17/2006 | CA2238817C 1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives |
| 10/12/2006 | WO2006108103A1 Purine and imidazopyridine derivatives for immunosuppression |
| 10/12/2006 | WO2006108040A1 Substituted indoles and their use as integrin antagonists |
| 10/12/2006 | WO2006107853A2 Pyrazolopyridine-1,4-diamines and analogs thereof |
| 10/12/2006 | WO2006107851A1 1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases |
| 10/12/2006 | WO2006107771A2 PYRAZOLO[3,4-c]QUINOLINES, PYRAZOLO[3,4-c]NAPHTHYRIDINES, ANALOGS THEREOF, AND METHODS |
| 10/12/2006 | WO2006107753A2 Pyrazolopyridines and analogs thereof |
| 10/12/2006 | WO2006107254A1 Novel diazaspiroalkanes and their use for treatment of ccr8 mediated diseases |
| 10/12/2006 | WO2006107253A1 Novel diazaspiroalkanes and their use for treatment of ccr8 mediated diseases |
| 10/12/2006 | WO2006107252A1 Novel diazaspiroalkanes and their use for treatment of ccr8 mediated diseases |
| 10/12/2006 | WO2006106963A1 Triamine derivative |
| 10/12/2006 | WO2006106804A1 Tricyclic spiro compound comprising acyl group bound to nitrogen atom in the ring |
| 10/12/2006 | WO2006106046A1 Substituted 1,5-naphthyridine azolidinones as cdk inhibitors |
| 10/12/2006 | WO2006105971A1 Substituted 5,6,7,8-tetrahydro-imidazo[1,2-a]pyridin-2-ylamine compounds and their use for producing drugs |
| 10/12/2006 | WO2006073938A3 Method for the synthesis of 3-substituted indolizine and benzoindolizine compounds |
| 10/12/2006 | WO2006066914A3 Carbamate substituted imidazo- and pyrrolo-pyridines as protein kinase inhibitors |
| 10/12/2006 | WO2006061217A3 Saquinavir derivatives useful in immunoassay |
| 10/12/2006 | WO2006059304A3 Novel lactame derivatives as renin inhibitors |
| 10/12/2006 | WO2005123703A3 Alkynyl derivatives as modulators of metabotropic glutamate receptors |
| 10/12/2006 | WO2005023760A3 Metal complexes of n-heterocyclic carbenes as radiopharmaceuticals and antibiotics |
| 10/12/2006 | US20060229334 Biphenyl derivatives |
| 10/12/2006 | US20060229329 Such as 2-anilino-4-(6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl)pyrimidine; antiproliferative agents; rheumatoid arthritis |
| 10/12/2006 | US20060229315 3-Substituted Quinoline-4-Carboxamide Derivatives as NK-3 and NK-2 Receptor Antagonists |
| 10/12/2006 | US20060229311 Isatine derivatives with neurotrophic activity |
| 10/12/2006 | US20060229307 partial antagonists and partial agonists of vanilloid-1 receptor (VR1); N-(4-trifluoromethylphenyl)-2-(3-trifluoromethyl-2-pyridinyl)pyrido[2,3-d]pyridazin-5-amine; antiinflammatory and analgesic agent |
| 10/12/2006 | US20060229303 antibiotics, fungicides, viricides; treating microbial infections; fused rings based on 1,4-benzoxazino(2,3,4-ij)quinolin-4-one for example |
| 10/12/2006 | US20060229301 To treat inflammatory diseases, immune diseases like autoimmune diseases or allergic diseases, or HIV infection; chemokine receptor antagonists; safe and low-toxic; 1-butyl-3-isobutyl-1,3,8-triazaspiro[4.5]decane-2,4-dione |
| 10/12/2006 | US20060229300 Method for the preparation of enantiomerically pure mirtazapine |
| 10/12/2006 | US20060229298 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues |
| 10/12/2006 | US20060229294 Benzisothiazoles useful for treating or preventing HCV infection |
| 10/12/2006 | US20060229196 Catalyzing the oxidation, carbonylation, nitration, sulfonation reaction; catalyst selectivity; produce terephthalic acid from p-xylene or from p-toluic acid; produce pyromellitic acid from durene |
| 10/12/2006 | DE102005016547A1 Substituierte 5,6,7,8-Tetrahydro-imidazo(1,2-a)pyridin-2-ylamin-Verbindungen und deren Verwendung zur Herstellung von Arzneimitteln Substituted 5,6,7,8-tetrahydro-imidazo (1,2-a) pyridin-2-ylamine compounds and their use for preparing medicaments |
| 10/12/2006 | CA2604161A1 Purine and imidazopyridine derivatives for immunosuppression |
| 10/12/2006 | CA2603063A1 Pyrazolo[3,4-c]quinolines, pyrazolo[3,4-c]naphthyridines, analogs thereof, and methods |
| 10/12/2006 | CA2602800A1 Pyrazolopyridines and analogs thereof |
| 10/12/2006 | CA2602757A1 Substituted 1,5-naphthyridine azolidinones as cdk inhibitors |
| 10/12/2006 | CA2602683A1 Pyrazolopyridine-1,4-diamines and analogs thereof |
| 10/12/2006 | CA2602623A1 Substituted 5,6,7,8-tetrahydro-imidazo[1,2-a]pyridin-2-ylamine compounds and their use for producing drugs |
| 10/12/2006 | CA2602590A1 1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases |